Analyzing Market Dynamics in Viral Gastroenteritis Market || Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Viral Gastroenteritis Global Market Report 2023 identifies the increasing prevalence of gastrointestinal disorders is expected to propel the growth of the viral gastroenteritis market going forward. Gastrointestinal (GI) disorders refer to a disease that occurs within or on any part of the gastrointestinal tract. Viral gastroenteritis drugs and diagnosis treatments help people suffering from the illness with proper and appropriate medication. For instance, in October 2021, according to a survey report across 33 countries among 73,076 adults by Bodibio, a US-based fitness and wellness company, 40% of those surveyed had a functional gastrointestinal disorder, including all the variations of functional dyspepsia, irritable bowel syndrome, functional constipation, and others.

The global viral gastroenteritis market is expected to grow from $5.99 billion in 2022 to $6.34 billion in 2023 at a compound annual growth rate (CAGR) of 6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The viral gastroenteritis market is expected to reach $7.68 billion in 2027 at a CAGR of 4.9%.

Download Free Sample Of Viral Gastroenteritis Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=12127&type=smp

Major competitors in the viral gastroenteritis market are Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., C.H. Boehringer Sohn AG & Co. KG, Daiichi Sankyo Company Limited, Regeneron Pharmaceuticals Inc., Mylan N.V.

A key trend in the viral gastroenteritis market includes product innovation.Major companies operating in the viral gastroenteritis market are focusing on developing new products to strengthen their position in the market. For instance, in November 2022, GlaxoSmithKline plc, a UK-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for its oral-dosing applicator-only presentation (liquid formulation) of ROTARIX to prevent rotavirus gastroenteritis in infants. This new presentation formulation becomes more convenient for healthcare providers by eliminating the need to reconstitute the vaccine dose at the point of use

Read More On The Global Viral Gastroenteritis Market Report Here: https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

The viral gastroenteritis market is segmented -

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

6) By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the viral gastroenteritis market.

The Business Research Company's "Global Viral Gastroenteritis Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Viral Gastroenteritis Market Report Here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12127

The Table Of Content For The Viral Gastroenteritis Market Include:
1. Executive Summary
2. Viral Gastroenteritis Market Characteristic
3. Viral Gastroenteritis Market Trends And Strategies
4. Viral Gastroenteritis Market - Macro Economic Scenario
5. Viral Gastroenteritis Market Size And Growth
……………
27. Viral Gastroenteritis Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Viral Gastroenteritis Market
29. Viral Gastroenteritis Market Future Outlook And Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.